Latiotim (Timolol Maleate, Latanoprost)

Latiotim is used to manage conditions that involve elevated intra‑ocular pressure within the glaucoma disease family.

• Open‑angle glaucoma: reduces intra‑ocular pressure to slow progression of optic nerve damage.
• Ocular hypertension: lowers eye pressure to decrease the risk of developing glaucoma.
• Post‑surgical ocular hypertension: maintains target pressure after glaucoma surgery.

• Timolol maleate is a non‑selective beta‑adrenergic antagonist that reduces aqueous humor production by blocking β1 and β2 receptors in the ciliary body. Latanoprost is a prostaglandin F2α analogue that increases uveoscleral outflow of aqueous humor by remodeling extracellular matrix in the iris‑ciliary body. The combined actions decrease intra‑ocular pressure more effectively than either component alone, providing complementary pressure‑lowering effects.

Latiotim may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Eye irritation or burning on instillation.
• Transient blurred vision.
• Conjunctival hyperemia.
• Dry eye sensation.

Serious or Rare Side Effects

• Severe allergic reaction such as angio‑edema or anaphylaxis.
• Significant reduction in heart rate or bronchospasm in susceptible patients.
• Persistent ocular inflammation or uveitis.
• Darkening of the iris or periorbital skin.

Before prescribing Latiotim, clinicians should consider several precautionary measures to ensure patient safety.

• Cardiovascular disease: assess for bradycardia, heart block, or heart failure before use.
• Respiratory conditions: avoid in patients with asthma or chronic obstructive pulmonary disease due to beta‑blocker effects.
• Pregnancy and lactation: use only if potential benefit justifies potential risk; data are limited.
• Contact lens wearers: advise removal before instillation and wait before reinserting to prevent lens discoloration.
• Systemic drug interactions: review concomitant beta‑blockers or prostaglandin analogs for additive effects.
• Store below 25°C: keep in original bottle, protect from light and moisture.

Latiotim can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Systemic non‑selective beta‑blockers (e.g., propranolol): may cause excessive bradycardia or hypotension.
• Other ocular prostaglandin analogues: combined use can increase risk of ocular hyperemia and iris pigmentation changes.
• Monoamine oxidase inhibitors: may potentiate systemic beta‑blocker effects, leading to severe hypotension.

Moderate Interactions (Monitor Closely)

• Carbonic anhydrase inhibitors (oral or topical): additive intra‑ocular pressure lowering may require dose adjustment.
• Anticholinergic eye drops: may reduce pupil dilation, affecting visual assessment.
• NSAID eye drops: may increase ocular irritation when used together.